Publication
Yoshinori Kagawa
【受賞】
第64回 日本消化器外科学会学術総会 優秀賞 （2009）
第56回 関西STOMA研究会 最優秀賞 （2014）
第2回 大阪大学消化器外科 手術ビデオ賞（2016）
第39回 癌局所療法研究会 優秀賞 (2017)
第39回 日本ストーマ・排泄リハビリテーション学会 優秀演題（2022）
第22回 大阪病院学会 優秀賞 (2023)
第36回 日本内視鏡外科学会 優秀演題賞 (2023)
【学位】
大阪大学大学院消化器外科学 博士課程修了
研究テーマ
がん細胞の生体イメージング「がんの細胞周期と浸潤について」
２光子顕微鏡を用いた生体内でのがん細胞の細胞周期の可視化
【取得研究】
文部科学省 2012年度科研費 若手B 賀川義規（がんの生体イメージング）
文部科学省 2024年度科研費 Radiogenopathomicsに基づく局所進行直腸癌に対するTNTの効果予測AIモデルを構築 基盤C 賀川義規
【特許】
国内特許 新規抗腫瘍剤及びそのスクリーニング方法 特許第5854569号 (P5854569) 賀川義規、石井優、森正樹ら
国際特許 Novel antitumor agent and method for screening same WO 2013111897 A1 Y.Kagaawa、M.Ishii、M.Moriら
【論文】
1. Kagawa Y, Smith JJ, Fokas E, Watanabe J, Cercek A, Greten FR, Bando H, Shi Q, Garcia-Aguilar J, Romesser PB, Horvat N, Sanoff H, Hall W, Kato T, Roedel C, Dasari A, Yoshino T. Future direction of total neoadjuvant therapy for locally advanced rectal cancer. Nature Reviews Gastroenterology & Hepatology.12. 2024
2. Kagawa Y, Elez E, García-Foncillas J, Bando H, Taniguchi H, Vivancos A, Akagi K, García A, Denda T, Ros J, Nishina T, Baraibar I, Komatsu Y, Ciardiello D, Oki E, Kudo T, Kato T, Yamanaka T, Tabernero J, Yoshino T. Combined Analysis of Concordance between Liquid and Tumor Tissue Biopsies for RAS Mutations in Colorectal Cancer with a Single Metastasis Site: The METABEAM Study. Clinical Cancer Research.27(9):2515-22. 2021
3. Kagawa Y, Shinozaki E, Okude R, Tone T, Kunitomi Y, Nakashima M. Real-world evidence of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer using an administrative claims database in Japan. ESMO Open.8(4):101614. 2023
4. Kagawa Y, Watanabe J, Ando K, Kitchens C, Bercz A, Smith JJ. Integrating Immune Checkpoint Inhibitors With Total Neoadjuvant Therapy in Proficient Mismatch Repair Rectal Cancer. Annals of Gastroenterological Surgery. 2025
5. Kagawa Y, Watanabe J, Uemura M, Ando K, Inoue A, Oba K, Takemasa I, Oki E. Short-term outcomes of a prospective multicenter phase II trial of total neoadjuvant therapy for locally advanced rectal cancer in Japan (ENSEMBLE-1). Annals of Gastroenterological Surgery.7(6):968-76. 2023
6. Kagawa Y, Ando K, Uemura M, Watanabe J, Oba K, Emi Y, Matsuhashi N, Izawa N, Muto O, Kinjo T, Takemasa I, Oki E. Phase II study of long-course chemoradiotherapy followed by consolidation chemotherapy as total neoadjuvant therapy in locally advanced rectal cancer in Japan: ENSEMBLE-2. Annals of Gastroenterological Surgery.8(6):1067-75. 2024
7. Kagawa Y. Clinical implications of a machine learning model predicting colorectal polyp recurrence after endoscopic mucosal resection. World J Gastroenterol.31(22):107197. 2025
8. Kagawa Y, Hata S, Shimizu J, Sekimoto M, Mori M. Transumbilical laparoscopic-assisted appendectomy for children and adults. International Journal of Colorectal Disease.27(3):411-3. 2012
9. Kagawa Y, Kato T, Naito A, Morimoto Y, Sato Y, Kuwahara R, Ishida T, Oneda Y, Murakami K, Inatome J, Katsura Y, Ohmura Y, Takeno A, Egawa C, Takeda Y, Tamura S. Single-site laparoscopic right hemicolectomy for acute cecal volvulus: a case report. Surg Case Rep.2(1):51. 2016
10. Kagawa Y, Matsumoto S, Kamioka Y, Mimori K, Naito Y, Ishii T, Okuzaki D, Nishida N, Maeda S, Naito A, Kikuta J, Nishikawa K, Nishimura J, Haraguchi N, Takemasa I, Mizushima T, Ikeda M, Yamamoto H, Sekimoto M, Ishii H, Doki Y, Matsuda M, Kikuchi A, Mori M, Ishii M. Cell cycle-dependent Rho GTPase activity dynamically regulates cancer cell motility and invasion in vivo. PLoS One.8(12):e83629. 2013
11. Kagawa Y, Osaka T, Imamura T, Kuwabara H. Treatment Sequences in Patients with Metastatic Colorectal Cancer in Japan: Real-World Evidence of First- to Fifth-Line Treatments. Cancers.17(24):14. 2025
12. Kagawa Y, Ota K. Enhancing laparoscopic inguinal hernia repair with three-dimensional computed tomography reconstruction. World Journal of Gastrointestinal Endoscopy.17(6):4. 2025
13. Kagawa Y, Wang CC, Piao YZ, Jin L, Tanizawa Y, Cai ZH, Sunakawa Y. Real-World Evidence of FOLFIRI Combined with Anti-Angiogenesis Inhibitors or Anti-EGFR Antibodies for Patients with Early Recurrence Colorectal Cancer After Adjuvant FOLFOX/CAPOX Therapy: A Japanese Claims Database Study. Targeted Oncology.19(3):359-70. 2024
14. Kagawa Y, Watanabe J, Ando K. DNA-dependent protein kinase inhibitor as a sensitizer of radiotherapy in locally advanced rectal cancer. Journal of Gastrointestinal Oncology.15(5):2358-62. 2024
15. Kagawa Y, Watanabe J, Ando K. The UNION trial: open the door to immune checkpoint inhibitors for proficient mismatch repair/microsatellite stability rectal cancer? AME Clinical Trials Review. 2025
16. Kagawa Y, Watanabe J, Ando K, Kitchens C, Bercz A, Smith JJ. Integrating Immune Checkpoint Inhibitors With Total Neoadjuvant Therapy in Proficient Mismatch Repair Rectal Cancer. Annals of Gastroenterological Surgery.10(1):145-53. 2026
17. Kagawa Y, Yamada D, Yamasaki M, Miyamoto A, Mizushima T, Yamabe K, Imazato M, Fukunaga H, Kobayashi S, Shimizu J, Umeshita K, Ito T, Doki Y, Mori M. The association between the increased performance of laparoscopic colon surgery and a reduced risk of surgical site infection. Surgery Today.49(6):474-81. 2019
18. Ushimaru Y, Omori T, Yamamoto K, Yamamoto K, Masuike Y, Yanagimoto Y, Matsuura N, Sugase T, Kanemura T, Mori R, Kitakaze M, Kubo M, Fukuda Y, Komatsu H, Miyo M, Sueda T, Kagawa Y, Gotoh K, Kobayashi S, Miyata H. A single-center retrospective study of conversion surgery in stage IV gastric cancer: association with immune checkpoint inhibitor-based chemotherapy. Journal of Gastrointestinal Surgery.30(2):9. 2026
19. Sugase T, Kanemura T, Matsuura N, Sugimura K, Takeoka T, Yamamoto K, Ushimaru Y, Masuike Y, Yanagimoto Y, Yamamoto K, Mori R, Kitakaze M, Kubo M, Fukuda Y, Komatsu H, Miyo M, Sueda T, Kagawa Y, Gotoh K, Kobayashi S, Miyata H. Clinical outcomes of 23-mm circular stapled cervical anastomosis after esophagectomy. Esophagus.23(1):139-48. 2026
20. Kubo M, Iwai E, Akita H, Gotoh K, Fukuda Y, Komatsu H, Yamamoto K, Mori R, Kitakaze M, Matsuura N, Masuike Y, Sugase T, Ushimaru Y, Mio M, Yanagimoto Y, Kanemura T, Sueda T, Kagawa Y, Yamamoto K, Nishimura J, Miyata H, Kusuhara H, Abera K, Kobayashi S. Effect of a preoperative coating agent on postoperative skin tears in pancreatectomy. Surgery.192:6. 2026
21. Ando K, Hamabe A, Nakamura Y, Watanabe J, Hirata K, Kataoka K, Miyo M, Kato K, Akazawa N, Kagawa Y, Yokota M, Yamazaki K, Mishima S, Yukami H, Kotani D, Bando H, Laliotis G, Sharma S, Palsuledesai CC, Rabinowitz M, Jurdi A, Liu MC, Aleshin A, Taniguchi H, Takemasa I, Kato T, Yoshino T, Oki E. Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study. Annals of Surgery.283(1):13-21. 2026
22. Yanagimoto Y, Yamamoto K, Hara K, Masuike Y, Ushimaru Y, Kitamura M, Honma K, Matsuura N, Sugase T, Kanemura T, Mori R, Kitakaze M, Amisaki M, Kubo M, Mukai Y, Komatsu H, Sueda T, Kagawa Y, Nishimura J, Wada H, Goto K, Yasui M, Omori T, Miyata H. Two cases of protein-losing enteropathy induced by zolbetuximab in patients with unresectable advanced gastric cancer. Japanese Journal of Clinical Oncology.55(7):825-31. 2025
23. Ushimaru Y, Yamamoto K, Yanagimoto Y, Masuike Y, Yamamoto K, Matsuura N, Sugase T, Kanemura T, Mori R, Kitakaze M, Kubo M, Fukuda Y, Komatsu H, Miyo M, Sueda T, Kagawa Y, Gotoh K, Kobayashi S, Miyata H. Conversion surgery following zolbetuximab-based chemotherapy for CLDN18.2-positive gastroesophageal junction cancer. International Cancer Conference Journal.14(4):503-12. 2025
24. Ushimaru Y, Yamamoto K, Kawabata R, Yanagimoto Y, Odagiri K, Takeoka T, Masuike Y, Yamamoto K, Matsuura N, Sugase T, Kanemura T, Mori R, Kitakaze M, Amisaki M, Kubo M, Fukuda Y, Komatsu H, Miyo M, Sueda T, Kagawa Y, Gotoh K, Kobayashi S, Miyata H. Robotic esophageal reconstruction with a diagonal stapling technique: technical description and early outcomes from a single-center series. Surgical Endoscopy and Other Interventional Techniques.39(12):8659-68. 2025
25. Ushimaru Y, Omori T, Yamamoto K, Yanagimoto Y, Masuike Y, Matsuura N, Sugase T, Kanemura T, Mori R, Kitakaze M, Amisaki M, Kubo M, Mukai Y, Komatsu H, Sueda T, Kagawa Y, Wada H, Gotoh K, Yasui M, Miyata H. Robotic and laparoscopic gastrectomy for gastric cancer: comparative insights into perioperative performance and three-year survival outcomes. Gastric Cancer.28(3):514-26. 2025
26. Uemura M, Kusunoki C, Sekido Y, Takeda M, Hata T, Hamabe A, Ogino T, Miyoshi N, Tei M, Kagawa Y, Eguchi H, Doki Y. Saireito (TJ-114) for Preventing High-Output Syndrome After Temporary Ileostomy in Rectal Cancer Surgery. International Journal of Colorectal Disease.40(1):7. 2025
27. Uemura M, Kusunoki C, Nakajo S, Osaki M, Kusafuka H, Sekido Y, Takeda M, Hata T, Hamabe A, Ogino T, Miyoshi N, Kagawa Y, Tei M, Doki Y, Eguchi H. Intraoperative visualization of lymphatic flow along the ileocolic artery using ICG fluorescence imaging and its implications for right-sided colon cancer surgery. Surgical Endoscopy and Other Interventional Techniques.39(9):5872-8. 2025
28. Tsuchiya Y, Sugimoto K, Nojiri S, Kojima Y, Sakamoto K, Fujii Y, Takeshita H, Taketa T, Akagi T, Nakajima K, Nakamura T, Kagawa Y, Ohnuma S, Inomata M, Yamamoto S, Naitoh T. Risk Factors for Conversion to an Open Surgery during Laparoscopic Surgery for Patients with Colon Cancer with Body Mass Index ≥25 kg/m2. Journal of the Anus Rectum and Colon.9(4):428-36. 2025
29. Takiguchi N, Uemura M, Osaki M, Kusunoki C, Paku M, Takeda M, Sekido Y, Hata T, Hamabe A, Ogino T, Miyoshi N, Tei M, Kagawa Y, Yamamoto H, Doki Y, Eguchi H. Clinical Significance of Copper Chaperone for Superoxide Dismutase in Colorectal Cancer. Annals of Gastroenterological Surgery.8. 2025
30. Takahashi H, Saso K, Ohue M, Noura S, Tanida T, Komori T, Tei M, Kagawa Y, Morita S, Okamura S, Miyake M, Miyoshi N, Uemura M, Fujii M, Ohno Y, Yamamoto H, Murata K, Doki Y, Eguchi H, Clinical Study Grp Osaka U, Colorectal Canc Treatment Grp C. Efficacy of lymph node dissection around the inferior mesenteric artery with preservation of the left colic artery for rectal cancer. Annals of Gastroenterological Surgery.9(2):298-308. 2025
31. Sugase T, Kanemura T, Matsuura N, Takeoka T, Ushimaru Y, Masuike Y, Yanagimoto Y, Yamamoto K, Omori T, Mori R, Kitakaze M, Kubo M, Mukai Y, Komatsu H, Sueda T, Kagawa Y, Wada H, Yasui M, Miyata H. Survival Impact of Adjuvant Nivolumab Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemotherapy with Docetaxel Plus 5-Fluorouracil and Cisplatin. Annals of Surgical Oncology.32(8):5887-97. 2025
32. Sugase T, Kanemura T, Matsuura N, Takeoka T, Ushimaru Y, Masuike Y, Yanagimoto Y, Yamamoto K, Omori T, Mori R, Kitakaze M, Kubo M, Mukai Y, Komatsu H, Sueda T, Kagawa Y, Wada H, Goto K, Yasui M, Miyata H. Safety and short-term outcomes of adjuvant nivolumab therapy at 480 mg dose every four weeks in resected esophageal cancer: a prospective cohort study. Esophagus.22(4):565-73. 2025
33. Sugase T, Kanemura T, Matsuura N, Sugimura K, Takeoka T, Yamamoto K, Ushimaru Y, Masuike Y, Yanagimoto Y, Yamamoto K, Mori R, Kitakaze M, Kubo M, Fukuda Y, Komatsu H, Miyo M, Sueda T, Kagawa Y, Gotoh K, Kobayashi S, Miyata H. Clinical outcomes of 23-mm circular stapled cervical anastomosis after esophagectomy. Esophagus.10. 2025
34. Sugase T, Kanemura T, Matsuura N, Sugimura K, Takeoka T, Ushimaru Y, Masuike Y, Yanagimoto Y, Mori R, Kitakaze M, Kubo M, Mukai Y, Komatsu H, Sueda T, Kagawa Y, Nishimura J, Wada H, Yasui M, Miyata H. Clinical outcomes of pembrolizumab plus chemotherapy for postoperative recurrent esophageal squamous cell carcinoma. Diseases of the Esophagus.38(3):11. 2025
35. Sueda T, Yasui M, Nishimura J, Kagawa Y, Kitakaze M, Mori R, Yanagimoto Y, Kanemura T, Yamamoto K, Wada H, Gotoh K, Miyata H, Ohue M. Short- and long-term outcomes of robotic versus conventional laparoscopic surgery for middle or lower rectal cancer: a propensity score-matched analysis. International Journal of Colorectal Disease.40(1):13. 2025
36. Sueda T, Yasui M, Nishimura J, Kagawa Y, Kitakaze M, Mori R, Matsuda C, Ushimaru Y, Sugase T, Mukai Y, Komatsu H, Yanagimoto Y, Kanemura T, Yamamoto K, Wada H, Goto K, Miyata H, Ohue M. Learning curve analysis for prophylactic bilateral robot-assisted lateral lymph node dissection for lower rectal cancer: a retrospective study. Techniques in Coloproctology.29(1):12. 2025
37. Sueda T, Nishimura J, Yamamura A, Yasui M, Kagawa Y, Miyo M, Kitakaze M, Mori R, Katsuta I, Higuchi M, Furukawa K, Fujii N, Hiuge Y, Ohashi Y, Iida H, Okawa M, Kuri M, Tanigami H, Ohue M. Impact of prophylactic 5-hydroxytryptamine-3 receptor antagonist on postoperative nausea and vomiting in patients undergoing laparoscopic or robotic colorectal cancer surgery: a propensity score-matched analysis. Surgery Today.55(11):1743-51. 2025
38. Nakajima K, Akagi T, Kono Y, Shiroshita H, Ohyama T, Saito S, Kagawa Y, Nakamura T, Ohnuma S, Kojima Y, Inomata M, Yamamoto S, Naitoh T, Sakai Y, Watanabe M, Japan Society of Laparoscopic Colorectal S. Laparoscopic versus open colectomy for locally advanced colon cancer in obese patients: a nationwide, multicenter, propensity score-based analysis of short- and long-term outcomes. Jpn J Clin Oncol.55(1):21-8. 2025
39. Miyo M, Uemura M, Ozato Y, Nishimura J, Nakata K, Suzuki Y, Kagawa Y, Hata T, Munakata K, Tei M, Sawada G, Yoshioka S, Takahashi Y, Oba K, Hata T, Ogino T, Miyoshi N, Yamamoto H, Murata K, Doki Y, Eguchi H, Clinical Study Grp Osaka Univ Colorectal Grp CC. Influence of the rotation of the diverting loop ileostomy in rectal cancer surgery on small-bowel obstruction: A multicenter prospective study conducted by the Clinical Study Group of Osaka University, Colorectal Group. Surgery.178:7. 2025
40. Miyo M, Shiomi A, Lee SW, Fukunaga Y, Hiro J, Kinugasa Y, Nomura A, Ohno R, Kawai K, Yasui M, Yamakawa Y, Takahashi H, Miura T, Murata K, Kotake M, Katsuno H, Kobayashi A, Yokota M, Matsuhashi N, Tei M, Hasegawa S, Ozawa M, Takano Y, Kanemitsu Y, Hazama H, Nonaka T, Ishizaki T, Uemura M, Obatake M, Kagawa Y, Ishihara S, Okuya K, Sakai Y, Watanabe M, Takemasa I. Short-term outcomes of robot-assisted ultralow anterior resection and robot-assisted rectectomy with transanal anastomosis for rectal cancer in Japan: A multicenter retrospective cohort study (ROSEMARY study). Surgery.184:7. 2025
41. Masuike Y, Omori T, Yamamoto K, Yanagimoto Y, Ushimaru Y, Yamamoto K, Kanemura T, Sugase T, Matsuura N, Mori R, Kitakaze M, Kubo M, Fukuda Y, Komatsu H, Miyo M, Sueda T, Kagawa Y, Goto K, Kobayashi S, Ohue M, Miyata H. Postoperative chemotherapy after conversion surgery for clinical stage IV gastric cancer: a propensity score-matched analysis. International Journal of Clinical Oncology.30(11):2296-306. 2025
42. Ma J, Lin HW, Wang Y, Zhang YM, Zhou CP, Tang DB, Kagawa Y, Hou DR, Jiang GQ. The unique role of cuproptosis in the prognosis and treatment of rectum adenocarcinoma. Journal of Gastrointestinal Oncology.16(2):20. 2025
43. Kojitani Y, Sakai D, Ogata T, Amano Y, Mori R, Kitakaze M, Sueda T, Otsuka T, Nishio M, Ishihara M, Kagawa Y, Nishimura J, Sugimoto N, Yagi T, Takeda M, Yasui M, Kudo T. Clinical and prognostic characteristics of metastatic colorectal cancer with minor RAS mutations. Oncology Letters.30(2):8. 2025
44. Inoue A, Kagawa Y, Nishizawa Y, Komori T, Hashimoto M, Ozato Y, Morimoto Y, Shimamoto S, Miyazaki Y, Tomokuni A, Motoori M, Fujitani K. Outcomes of neoadjuvant chemoradiotherapy for locally advanced rectal cancer under non-smoking conditions confirmed by measuring expiratory CO levels: An observational study. Oncology Letters.29(6):8. 2025
45. Hisamatsu Y, Ando K, Kudo K, Nakanishi R, Kawazoe T, Zaitsu Y, Kusumoto T, Hata T, Kagawa Y, Yoshizumi T, Ashida N, Niiro H, Hirose T, Oki E. A 14-Gene Panel for Predicting Colorectal Cancer Recurrence Using Circulating Tumor DNA in Different Testing Conditions. Cancer Science.116(9):2499-506. 2025
46. Hashimoto M, Nishizawa Y, Kagawa Y, Inoue A, Kato S, Morimoto Y, Tomokuni A, Motoori M, Hata T, Fujitani K. Short-term clinical outcomes and cost analysis of intracorporeal anastomosis with laparoscopic and robotic staplers during robot-assisted right colon resection: a single-center retrospective study. Journal of Robotic Surgery.19(1):8. 2025
47. Hamabe A, Uemura M, Suwa Y, Nishizawa Y, Kagawa Y, Kimura K, Kondo A, Kato T, Katsuno G, Nitta T, Takano Y, Nagayoshi K, Miyanaga S, Matsuda T, Kawamura J, Watanabe J. The SPECTACLE Study: A Multicenter, Prospective, Single-Arm Trial Evaluating Quantitative Blood Flow Assessment Using SPY-QP Software in Minimally Invasive Rectal Cancer Surgery. Asian Journal of Endoscopic Surgery.19(1):5. 2025
48. Aiba T, Akagi T, Shiroshita H, Nakajima K, Ohyama T, Kinjo T, Kanazawa A, Suzuki N, Tokunaga T, Yamamoto M, Ichikawa N, Endo S, Kojima Y, Nakamura T, Saito S, Kagawa Y, Ohnuma S, Yamamoto S, Naitoh T, Inomata M. Impact of body mass index as a continuous variable on short- and long-term outcomes in patients undergoing laparoscopic surgery for colon cancer. Annals of Gastroenterological Surgery.9(3):392-400. 2025
49. Yamamoto Y, Yukami H, Yamaguchi T, Ohori H, Nagasu S, Kagawa Y, Sugimoto N, Sonoda H, Yamazaki K, Takashima A, Okuyama H, Hasegawa H, Kondo C, Baba E, Matsumoto T, Kawamoto Y, Kataoka M, Shindo Y, Ishikawa T, Esaki T, Kito Y, Sato T, Funakoshi T, Yamaguchi T, Shimada Y, Moriwaki T. Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: the JSCCR-TRIPON study. International Journal of Clinical Oncology.29(12):1878-86. 2024
50. Sugimoto N, Noura S, Kato T, Yoshioka S, Hata T, Naito A, Tei M, Tamagawa H, Komori T, Ide Y, Fukuzaki T, Danno K, Sawada G, Kagawa Y, Shimokawa T, Miyoshi N, Ogino T, Uemura M, Yamamoto H, Murata K, Doki Y, Eguchi H. The Efficacy of FOLFIRI Plus Ramucirumab in Recurrent Colorectal Cancer Refractory to Adjuvant Chemotherapy with Oxaliplatin/Fluoropyrimidine-Including Biomarker Analyses. Cancers (Basel).17(1). 2024
51. Sugase T, Kanemura T, Matsuura N, Ushimaru Y, Masuike Y, Yanagimoto Y, Mori R, Kitakaze M, Amisaki M, Kubo M, Mukai Y, Komatsu H, Sueda T, Kagawa Y, Nishimura J, Wada H, Yasui M, Omori T, Miyata H. Prognostic impact of dysphagia scores in patients with advanced resectable esophageal cancer who underwent radical esophagectomy after preoperative treatment. Journal of Gastrointestinal Surgery.28(11):1853-60. 2024
52. Sueda T, Yasui M, Nishimura J, Kagawa Y, Kitakaze M, Mori R, Noura S, Omori T, Miyata H, Ohue M. Prognostic impact of lateral sentinel lymph node biopsy using indocyanine green on oncological outcomes for clinical stage II/III lower rectal cancer without suspected lateral lymph node metastasis. Langenbecks Archives of Surgery.409(1):10. 2024
53. Osumi H, Shinozaki E, Nakamura Y, Esaki T, Yasui H, Taniguchi H, Satake H, Sunakawa Y, Komatsu Y, Kagawa Y, Denda T, Shiozawa M, Satoh T, Nishina T, Goto M, Takahashi N, Kato T, Bando H, Yamaguchi K, Yoshino T. Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy. Nature Communications.15(1):11. 2024
54. Oki E, Nakanishi R, Ando K, Takemasa I, Watanabe J, Matsuhashi N, Kato T, Kagawa Y, Kotaka M, Hirata K, Sugiyama M, Kusumoto T, Miyamoto Y, Toyosaki K, Kishimoto J, Kimura Y, Yoshizumi T, Nakamura Y. Recurrence monitoring using ctDNA in patients with metastatic colorectal cancer: COSMOS-CRC-03 and AURORA studies. Esmo Gastrointestinal Oncology.3:6. 2024
55. Nakamura Y, Watanabe J, Akazawa N, Hirata K, Kataoka K, Yokota M, Kato K, Kotaka M, Kagawa Y, Yeh KH, Mishima S, Yukami H, Ando K, Miyo M, Misumi T, Yamazaki K, Ebi H, Okita K, Hamabe A, Sokuoka H, Kobayashi S, Laliotis G, Aushev VN, Sharma S, Jurdi A, Liu MC, Aleshin A, Rabinowitz M, Bando H, Taniguchi H, Takemasa I, Kato T, Kotani D, Mori M, Yoshino T, Oki E. ctDNA-based molecular residual disease and survival in resectable colorectal cancer. Nature Medicine.30(11):3272-83. 2024
56. Nakamura Y, Tsukada Y, Matsuhashi N, Murano T, Shiozawa M, Takahashi Y, Oki E, Goto M, Kagawa Y, Kanazawa A, Ohta T, Ouchi A, Bando H, Uchigata H, Notake C, Ikematsu H, Yoshino T. Colorectal Cancer Recurrence Prediction Using a Tissue-Free Epigenomic Minimal Residual Disease Assay. Clinical Cancer Research.30(19):4377-87. 2024
57. Nakajima K, Akagi T, Kono Y, Shiroshita H, Ohyama T, Saito S, Kagawa Y, Nakamura T, Ohnuma S, Kojima Y, Inomata M, Yamamoto S, Naitoh T, Sakai Y, Watanabe M, Japan Society of Laparoscopic Colorectal S. Laparoscopic versus open colectomy for locally advanced colon cancer in obese patients: a nationwide, multicenter, propensity score-based analysis of short- and long-term outcomes. Jpn J Clin Oncol. 2024
58. Mizumoto R, Miyoshi N, Hayashi R, Kato S, Minami S, Takeda M, Sekido Y, Hata T, Hamabe A, Ogino T, Tei M, Kagawa Y, Uemura M, Doki Y, Eguchi H. Usefulness of a powered circular stapler compared with a manual circular stapler in patients undergoing colorectal cancer surgery: A retrospective cohort study and systematic review. Oncology Letters.28(5):8. 2024
59. Matsubara Y, Bando H, Kotani D, Kagawa Y, Harada K, Osumi H, Izawa N, Kawakami T, Boku S, Matsumoto T, Wakabayashi M, Yoshino T. BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer. Esmo Gastrointestinal Oncology.4:5. 2024
60. Kusunoki C, Uemura M, Takeda M, Sekido Y, Hata T, Hamabe A, Ogino T, Miyoshi N, Kagawa Y, Tei M, Eguchi H, Doki Y. Assessing risk factors for elevated creatine kinase levels as an indicator of compartment syndrome following laparoscopic or robot-assisted colorectal cancer surgery in the lithotomy-trendelenburg position. Surgical Endoscopy and Other Interventional Techniques.38(10):6139-45. 2024
61. Kusunoki C, Uemura M, Osaki M, Takiguchi N, Kitakaze M, Paku M, Sekido Y, Takeda M, Hata T, Hamabe A, Ogino T, Miyoshi N, Tei M, Kagawa Y, Kato T, Eguchi H, Doki Y. Postoperative venous thromboembolism after surgery for locally recurrent rectal cancer. Bmc Cancer.24(1):9. 2024
62. Kobayashi Y, Uemura M, Paku M, Kitakaze M, Tei M, Kagawa Y, Takeda M, Sekido Y, Hata T, Hamabe A, Ogino T, Miyoshi N, Doki Y, Eguchi H. Venous Thromboembolism Following Lateral Lymph Node Dissection for Rectal Cancer. Anticancer Research.44(2):695-701. 2024
63. Kataoka K, Mori K, Nakamura Y, Watanabe J, Akazawa N, Hirata K, Yokota M, Kato K, Kotaka M, Yamazaki K, Kagawa Y, Mishima S, Ando K, Miyo M, Yukami H, Laliotis G, Sharma S, Palsuledesai CC, Rabinowitz M, Jurdi A, Liu MC, Aleshin A, Kotani D, Bando H, Taniguchi H, Takemasa I, Kato T, Yoshino T, Oki E. Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: Subgroup analysis from CIRCULATE-Japan GALAXY. Ann Oncol. 2024
64. Ishiyama Y, Hirano Y, Shiozawa M, Otsuji E, Natsume S, Akagi T, Nakajima K, Kagawa Y, Ohnuma S, Saito S, Inomata M, Yamamoto S, Sakai Y, Watanabe M, Naitoh T, Japan Soc Laparoscopic Colorectal S. Risk factors of bleeding during rectal cancer surgery in obese patients in Japan. Asian Journal of Endoscopic Surgery.17(3):7. 2024
65. Hayashi Y, Motoori M, Miyazaki Y, Maekawa S, Nishizawa Y, Komatsu H, Inoue A, Kagawa Y, Tomokuni A, Fujitani K. Impact of the perioperative assessment of deglutition on postoperative respiratory complications in elderly patients undergoing gastrectomy for gastric cancer. Surgery Today.54(3):258-65. 2024
66. Hata T, Uemura M, Danno K, Yoshioka S, Matsuda C, Kagawa Y, Shingai T, Suzuki Y, Tei M, Tanida T, Komori T, Okamura S, Ota H, Takemoto H, Ogino T, Miyoshi N, Yamamoto H, Murata K, Doki Y, Eguchi H. Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer. Scientific Reports.14(1):7. 2024
67. Bando H, Kotani D, Satake H, Hamaguchi T, Shiozawa M, Kotaka M, Masuishi T, Yasui H, Kagawa Y, Komatsu Y, Oki E, Yamamoto Y, Kawakami H, Misumi T, Taniguchi H, Yamazaki K, Muro K, Yoshino T, Kato T, Tsuji A. QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFOXIRI+bevacizumab as first-line treatment in patients with mCRC. Med.5(9):18. 2024
68. Aoyama S, Miyazaki Y, Motoori M, Hirota M, Itami T, Matsumoto S, Hirano M, Aomatsu M, Goto T, Kitahara M, Ozato Y, Nishizawa Y, Komatsu H, Inoue A, Kagawa Y, Tomokuni A, Iwase K, Nishi H, Fujitani K. Cardiac tamponade complicating esophagectomy and retrosternal gastric tube reconstitution in a patient with an abnormal ascending aorta position: a case report. Surg Case Rep.10(1):48. 2024
69. Aoyama S, Inoue A, Kagawa Y, Komori T, Ozato Y, Nishizawa Y, Sugimoto T, Komatsu H, Hirota M, Miyazaki Y, Tomokuni A, Motoori M, Fushimi H, Yamamoto G, Akagi K, Iwase K, Fujitani K. Curative resection via right hemicolectomy and regional lymph node dissection for colonic adenomatous polyposis of unknown etiology with adenocarcinomas localized in the right side of the colon: a case report. Surgical Case Reports.10(1):7. 2024
70. Yuki S, Yamazaki K, Sunakawa Y, Taniguchi H, Bando H, Shiozawa M, Nishina T, Yasui H, Kagawa Y, Takahashi N, Denda T, Esaki T, Kawakami H, Satake H, Takashima A, Matsuhashi N, Kato T, Asano C, Abe Y, Nomura S, Yoshino T. Role of plasma angiogenesis factors in the efficacy of first-line chemotherapy combined with biologics in RAS wild-type metastatic colorectal cancer: Results from the GI-SCREEN CRC-Ukit study. Cancer Medicine.12(18):18702-16. 2023
71. Watanabe J, Kagawa Y, Chida K, Ando K, Kotani D, Oba K, Bando H, Hojo H, Shimamoto S, Sakashita S, Kuwata T, Tsuboyama T, Hosomi N, Uemura M, Uehara K, Ito M, Oki E, Takemasa I, Misugi E, Sledge G, Sumani K, Imoto S, Kato T, Yoshino T. Phase III trial of short-course radiotherapy followed by CAPOXIRI versus CAPOX in locally advanced rectal cancer: the ENSEMBLE trial. Esmo Gastrointestinal Oncology.1:9-14. 2023
72. Takiguchi N, Uemura M, Kitakaze M, Paku M, Takeda M, Sekido Y, Hata T, Hamabe A, Ogino T, Miyoshi N, Tei M, Kagawa Y, Yamamoto H, Doki Y, Eguchi H. High Level Sacral Bone Resection for Locally Recurrent Rectal Cancer. Anticancer Research.43(11):5061-6. 2023
73. Shiota T, Murata K, Kishimoto M, Yao T, Noura S, Morita S, Akiyoshi T, Okamura S, Imasato M, Furuhata T, Suto T, Takemasa I, Shingai T, Ueda M, Mizuno H, Hisamatsu Y, Takeda T, Fujii M, Kagawa Y, Sugihara K, Study Grp Appendiceal N. Clinicopathological features of appendiceal goblet cell adenocarcinoma in Japan: a multicenter retrospective study. Surgery Today.53(2):174-81. 2023
74. Nakamura Y, Yamashita R, Okamoto W, Komatsu Y, Yuki S, Ueno M, Kato K, Taniguchi H, Kagawa Y, Denda T, Hara H, Esaki T, Moriwaki T, Sunakawa Y, Oki E, Nagashima F, Nishina T, Satoh T, Kawakami H, Yamaguchi K, Ohtsubo K, Kato T, Horita Y, Tsuji A, Yasui H, Goto M, Hamamoto Y, Wakabayashi M, Ikeno T, Shitara K, Bando H, Tsuchihara K, Miki I, Ichiki H, Ohtsu A, Yoshino T. Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling Program. Jco Precision Oncology.7:11. 2023
75. Miyo M, Mizushima T, Nishimura J, Hata T, Tei M, Miyake Y, Kagawa Y, Noura S, Ikenaga M, Danno K, Ogawa A, Chinen Y, Hata T, Miyoshi N, Takahashi H, Uemura M, Yamamoto H, Murata K, Doki Y, Eguchi H, Osaka Univ Colorectal G. Impact of the COVID-19 pandemic on colorectal cancer surgery in Japan: Clinical Study Group of Osaka University?A multicenter retrospective study. Annals of Gastroenterological Surgery.7(1):121-30. 2023
76. Matsuda C, Kudo T, Morimoto Y, Kagawa Y, Tei M, Ide Y, Miyoshi N, Takahashi H, Uemura M, Takemasa I, Satoh T, Mizushima T, Murata K, Doki Y, Eguchi H, Multicenter Clinical Study Grp O, Colorectal Canc Treatment Grp M. A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer. Annals of Gastroenterological Surgery.7(1):81-90. 2023
77. Kuboki Y, Terazawa T, Masuishi T, Nakamura M, Watanabe J, Ojima H, Makiyama A, Kotaka M, Hara H, Kagawa Y, Sugimoto N, Kawakami H, Takashima A, Kajiwara T, Oki E, Sunakawa Y, Ishihara S, Taniguchi H, Nakajima TE, Morita S, Shirao K, Takenaka N, Ozawa D, Yoshino T. Trifluridine/tipiracil plus bevacizumab (BEV) vs. fluoropyrimidine-irinotecan plus BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial. British Journal of Cancer.128(10):1897-905. 2023
78. Kobayashi S, Bando H, Taketomi A, Takamoto T, Shinozaki E, Shiozawa M, Hara H, Yamazaki K, Komori K, Matsuhashi N, Kato T, Kagawa Y, Yokota M, Oki E, Komine K, Takahashi S, Wakabayashi M, Yoshino T. NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases. Bmc Cancer.23(1):7. 2023
79. Kato T, Kudo T, Kagawa Y, Murata K, Ota H, Noura S, Hasegawa J, Tamagawa H, Ohta K, Ikenaga M, Miyazaki S, Komori T, Uemura M, Nishimura J, Hata T, Matsuda C, Satoh T, Mizushima T, Ohno Y, Yamamoto H, Doki Y, Eguchi H. Phase II dose titration study of regorafenib in progressive unresectable metastatic colorectal cancer. Scientific Reports.13(1):8. 2023
80. Kato S, Miyoshi N, Fujino S, Minami S, Nagae A, Hayashi R, Sekido Y, Hata T, Hamabe A, Ogino T, Tei M, Kagawa Y, Takahashi H, Uemura M, Yamamoto H, Doki Y, Eguchi H. Treatment response prediction of neoadjuvant chemotherapy for rectal cancer by deep learning of colonoscopy images. Oncology Letters.26(5):9. 2023
81. Hata T, Kawai K, Naito A, Kagawa Y, Kitahara T, Hiraki M, Shinke G, Katsuyama S, Katsura Y, Ohmura Y, Masuzawa T, Takeno A, Takeda Y, Kato T, Murata K. Short- and Long-Term Outcomes of Single-Incision Laparoscopic Surgery for Right-Side Colon Cancer. European Surgical Research.63(4):196-202. 2023
82. Boku S, Satake H, Ohta T, Mitani S, Kawakami K, Suzuki Y, Matsumoto T, Terazawa T, Yamazaki E, Hasegawa H, Ikoma T, Uemura M, Yamaguchi T, Naito A, Ishizuka Y, Kurokawa Y, Sakai D, Kawakami H, Shimokawa T, Tsujinaka T, Kato T, Satoh T, Kagawa Y. TRESBIEN (OGSG 2101): encorafenib, binimetinib and cetuximab for early recurrent stage II/III BRAF V600E-mutated colorectal cancer. Future Oncology.18(38):4153-60. 2023
83. Watanabe J, Maeda H, Nagasaka T, Yokota M, Hirata K, Akazawa N, Kagawa Y, Yamada T, Shiozawa M, Ando T, Kato T, Mishima H, Sakamoto J, Oba K, Nagata N. Multicenter, single-arm, phase II study of the continuous use of panitumumab in combination with FOLFIRI after FOLFOX for RAS wild-type metastatic colorectal cancer: Exploratory sequential examination of acquired mutations in circulating cell-free DNA. International Journal of Cancer.151(12):2172-81. 2022
84. Utsumi M, Yamada T, Yamabe K, Katsura Y, Fukuchi N, Fukunaga H, Tanemura M, Shimizu J, Kagawa Y, Kobayashi S, Takahashi H, Tanaka K, Mizushima T, Eguchi H, Nakayama N, Makimoto K, Doki Y. Differences in risk factors for surgical site infection between laparotomy and laparoscopy in gastrointestinal surgery. Plos One.17(9):15. 2022
85. Terazawa T, Kato T, Goto M, Ohta K, Satake H, Noura S, Kagawa Y, Kawakami H, Hasegawa H, Yanagihara K, Shingai T, Nakata K, Kotaka M, Hiraki M, Konishi K, Nakae S, Sakai D, Kurokawa Y, Shimokawa T, Tsujinaka T, Satoh T. The Phase II Study of Panitumumab in Chemotherapy-Naive Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results. Oncologist. 2022
86. Takeyama H, Murata K, Takeda T, Fujii M, Kagawa Y, Kawachi H, Yamaguchi T, Noura S, Masuishi T, Inoue A, Takii Y, Suto T, Sakamoto K, Tei M, Kishimoto M, Yao T, Sugihara K, Study Grp Appendiceal N. Clinical Significance of Lymph Node Dissection and Lymph Node Metastasis in Primary Appendiceal Tumor Patients After Curative Resection: a Retrospective Multicenter Cohort Study. Journal of Gastrointestinal Surgery.26(1):128-40. 2022
87. Sumimoto S, Inoue A, Kagawa Y, Komori T, Nishizawa Y, Hirano M, Song XY, Matsumoto S, Itami T, Nakai S, Yokono Y, Komatsu H, Miyazaki Y, Tomokuni A, Matsuoka K, Motoori M, Iwase K, Fujitani K. Intra-abdominal desmoid-type fibromatosis successfully resected using laparoscopic fluorescence imaging with indocyanine green after intersphincteric resection for rectal cancer. Asian Journal of Endoscopic Surgery.15(1):192-6. 2022
88. Satake H, Kagawa Y, Shinozaki E, Tanizawa Y, Jin L, Cai ZH, Makiyama A. Real-World Data Analysis of Second-Line Antiangiogenic Targeted Treatments Following Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies and First-Line FOLFOX for Patients with Metastatic Colorectal Cancer. Advances in Therapy.39(6):2596-613. 2022
89. Ooki A, Morita S, Tsuji A, Iwamoto S, Hara H, Tanioka H, Satake H, Kataoka M, Kotaka M, Kagawa Y, Nakamura M, Shingai T, Ishikawa M, Miyake Y, Suto T, Hashiguchi Y, Yabuno T, Ando M, Sakamoto J, Yamaguchi K. Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial. Bmc Cancer.22(1):12. 2022
90. Mizukami T, Takahashi M, Sunakawa Y, Yuki S, Kagawa Y, Takashima A, Kato K, Hara H, Denda T, Yamamoto Y, Shiozawa M, Oki E, Okamoto W, Yoshino T, Nakajima TE. Genomic Landscape of Primary Tumor Site and Clinical Outcome for Patients with Metastatic Colorectal Cancer Receiving Standard-of-Care Chemotherapy. Targeted Oncology.17(3):343-53. 2022
91. Kato A, Miyoshi N, Ohtsuru T, Sakai D, Hasegawa J, Nakata K, Imasato M, Kato T, Ikenaga M, Kudo T, Tei M, Kagawa Y, Uemura M, Takahashi H, Satoh T, Mori M, Mizushima T, Yamamoto H, Murata K, Doki Y, Eguchi H. A Phase II Study of Dose-reductive XELOX Plus Bevacizumab in Elderly or Vulnerable Patients With Metastatic Colorectal Cancer (MCSGO-1202). Anticancer Research.42(4):1859-65. 2022
92. Bando H, Nakamura Y, Taniguchi H, Shiozawa M, Yasui H, Esaki T, Kagawa Y, Denda T, Satoh T, Yamazaki K, Sunakawa Y, Kato T, Goto M, Yuki S, Nishina T, Oki E, Shinozaki E, Matsuhashi N, Takahashi N, Tsuji A, Ohtsubo K, Wakabayashi M, Ikeno T, Hata M, Odegaard J, Yoshino T. Effects of Metastatic Sites on Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer. Jco Precision Oncology.6:15. 2022
93. Yamaguchi T, Murata K, Shiota T, Takeyama H, Noura S, Sakamoto K, Suto T, Takii Y, Nagasaki T, Takeda T, Fujii M, Kagawa Y, Mizushima T, Ohno Y, Yao T, Kishimoto M, Sugihara K, Study Grp Appendiceal Neoplasms JS. Clinicopathological Characteristics of Low-Grade Appendiceal Mucinous Neoplasm. Digestive Surgery.38(3):222-9. 2021
94. Takeno A, Masuzawa T, Katsuyama S, Murakami K, Kawai K, Katsura Y, Ohmura Y, Kagawa Y, Takeda Y, Hata T, Murata K. Robotic-assisted proximal gastrectomy using the double-flap technique for early gastric cancer with situs inversus totalis: a case report. Surgical Case Reports.7(1):4. 2021
95. Takase K, Sakamoto T, Takeda Y, Ohmura Y, Katsura Y, Shinke G, Kawai K, Murakami K, Kagawa Y, Masuzawa T, Takeno A, Hata T, Murata K. Safety and efficacy of laparoscopic repeat liver resection and re-operation for liver tumor. Scientific Reports.11(1):7. 2021
96. Takahashi T, Yamazaki K, Oki E, Shiozawa M, Mitsugi K, Makiyama A, Nakamura M, Ojima H, Kagawa Y, Matsuhashi N, Okuda H, Asayama M, Yuasa Y, Shimada Y, Manaka D, Watanabe J, Oba K, Yoshino T, Yoshida K, Maehara Y. Phase II study of trifluridine/tipiracil plus bevacizumab by RAS mutation status in patients with metastatic colorectal cancer refractory to standard therapies: JFMC51-1702-C7. Esmo Open.6(2):8. 2021
97. Shinozaki E, Makiyama A, Kagawa Y, Satake H, Tanizawa Y, Cai ZH, Piao YZ. Treatment sequences of patients with advanced colorectal cancer and use of second-line FOLFIRI with antiangiogenic drugs in Japan: A retrospective observational study using an administrative database. Plos One.16(2):18. 2021
98. Okuyama H, Kagawa Y, Masuishi T, Mishima S, Shirasu H, Ando K, Yuki S, Muro K, Yoshino T, Yamazaki K, Oki E, Komatsu Y, Tsuji A. Infusion-related reaction to ramucirumab plus FOLFIRI in patients with advanced colorectal cancer. International Journal of Clinical Oncology.26(11):2025-8. 2021
99. Oki E, Watanabe J, Sato T, Kagawa Y, Kuboki Y, Ikeda M, Ueno H, Kato T, Kusumoto T, Masuishi T, Yamaguchi K, Kanazawa A, Nishina T, Uetake H, Yamanaka T, Yoshino T. Impact of the 12-gene recurrence score assay on deciding adjuvant chemotherapy for stage II and IIIA/B colon cancer: the SUNRISE-DI study. Esmo Open.6(3):8. 2021
100. Nakata K, Komori T, Saso K, Ota H, Kagawa Y, Morita S, Noura S, Hayashi N, Uemura M, Matsuda C, Satoh T, Mizushima T, Murata K, Doki Y, Eguchi H, Multictr Clinical Study Grp O, Colorectal Canc Treatment Grp M. Pre-emptive oral clarithromycin reduces the skin toxicity of panitumumab treatment for metastatic colorectal cancer. International Journal of Colorectal Disease.36(12):2621-7. 2021
101. Nakajima H, Kotani D, Bando H, Kato T, Oki E, Shinozaki E, Sunakawa Y, Yamazaki K, Yuki S, Nakamura Y, Yamanaka T, Yoshino T, Ohta T, Taniguchi H, Kagawa Y. REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer. Bmc Cancer.21(1):6. 2021
102. Kato T, Kagawa Y, Kuboki Y, Gamoh M, Komatsu Y, Yasui H, Satake H, Oki E, Tanioka H, Kotaka M, Makiyama A, Denda T, Goto M, Yoshino T, Yamazaki K, Soeda J, Shibuya K, Iwata M, Oba K, Yamaguchi K. Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study. International Journal of Clinical Oncology.26(7):1238-47. 2021
103. Ishida T, Kagawa Y, Naito A, Kawai K, Hata T, Takeno A, Goto T, Yoshimura M, Nakatsuka S, Takeda Y, Kato T, Murata K. Sarcomatoid Carcinoma of the Transverse Colon With Extremely Aggressive Brain Metastases. International Surgery.105(1-3):596-602. 2021
104. Inoue A, Murata K, Komori T, Takeda T, Fujii M, Yamaguchi T, Yamaguchi T, Masuishi T, Shiota T, Morita S, Suzuki Y, Ito M, Kanemitsu Y, Shiozawa M, Yasui M, Kagawa Y, Sugihara K, Study Grp Appendiceal N. Open versus laparoscopic surgery for primary appendiceal tumors: a large multicenter retrospective propensity score-matched cohort study in Japan. Surgical Endoscopy and Other Interventional Techniques.35(10):5515-23. 2021
105. Hasegawa H, Taniguchi H, Nakamura Y, Kato T, Fujii S, Ebi H, Shiozawa M, Yuki S, Masuishi T, Kato K, Izawa N, Moriwaki T, Oki E, Kagawa Y, Denda T, Nishina T, Tsuji A, Hara H, Esaki T, Nishida T, Kawakami H, Sakamoto Y, Miki I, Okamoto W, Yamazaki K, Yoshino T. FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer. Cancer Science.112(1):314-22. 2021
106. Aoyama S, Motoori M, Miyazaki Y, Sugimoto T, Nishizawa Y, Komatsu H, Inoue A, Kagawa Y, Tomokuni A, Iwase K, Fujitani K. Successful treatment of remnant gastric cancer with afferent loop syndrome managed by percutaneous transhepatic cholangial drainage followed by elective gastrectomy: a case report. Surgical Case Reports.7(1):6. 2021
107. Terazawa T, Kato T, Goto M, Ohta K, Noura S, Satake H, Kagawa Y, Kawakami H, Hasegawa H, Yanagihara K, Shingai T, Nakata K, Kotaka M, Hiraki M, Konishi K, Nakae S, Sakai D, Kurokawa Y, Shimokawa T, Satoh T. Phase II Study of Panitumumab Monotherapy in Chemotherapy-Naive Frail or Elderly Patients with Unresectable RAS Wild-Type Colorectal Cancer: OGSG 1602. Oncologist. 2020
108. Satake H, Kato T, Oba K, Kotaka M, Kagawa Y, Yasui H, Nakamura M, Watanabe T, Matsumoto T, Kii T, Terazawa T, Makiyama A, Takano N, Yokota M, Okita Y, Matoba K, Hasegawa H, Tsuji A, Komatsu Y, Yoshino T, Yamazaki K, Mishima H, Oki E, Nagata N, Sakamoto J. Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study). Oncologist. 2020
109. Ooki A, Morita S, Tsuji A, Iwamoto S, Hara H, Tanioka H, Satake H, Kataoka M, Kotaka M, Kagawa Y, Nakamura M, Shingai T, Ishikawa M, Miyake Y, Suto T, Hashiguchi Y, Yabuno T, Ando M, Sakamoto J, Yamaguchi K. Disagreement between patient- and physician-reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial. Cancer Medicine.9(24):9419-30. 2020
110. Ooki A, Morita S, Iwamoto S, Hara H, Tanioka H, Satake H, Kataoka M, Kotaka M, Kagawa Y, Nakamura M, Shingai T, Ishikawa M, Miyake Y, Suto T, Hashiguchi Y, Yabuno T, Sakamoto J, Tsuji A, Ando M, Yamaguchi K. Patient-reported symptom burden as a prognostic factor in treatment with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial. Cancer Medicine.9(5):1779-89. 2020
111. Nose Y, Kagawa Y, Hata T, Mori R, Kawai K, Naito A, Sakamoto T, Murakami K, Katsura Y, Ohmura Y, Masuzawa T, Takeno A, Takeda Y, Kato T, Murata K. Neutropenia is an indicator of outcomes in metastatic colorectal cancer patients treated with FTD/TPI plus bevacizumab: a retrospective study. Cancer Chemother Pharmacol.86(3):427-33. 2020
112. Nakamura Y, Taniguchi H, Ikeda M, Bando H, Kato K, Morizane C, Esaki T, Komatsu Y, Kawamoto Y, Takahashi N, Ueno M, Kagawa Y, Nishina T, Kato T, Yamamoto Y, Furuse J, Denda T, Kawakami H, Oki E, Nakajima T, Nishida N, Yamaguchi K, Yasui H, Goto M, Matsuhashi N, Ohtsubo K, Yamazaki K, Tsuji A, Okamoto W, Tsuchihara K, Yamanaka T, Miki I, Sakamoto Y, Ichiki H, Hata M, Yamashita R, Ohtsu A, Odegaard J, Yoshino T. Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies. Nature Medicine.26(12):16. 2020
113. Matsui S, Murata K, Fukunaga Y, Takeda T, Fujii M, Yamaguchi T, Kagawa Y, Mizushima T, Ohno Y, Yao T, Doki Y, Sugihara K. Analysis of Clinicopathological Characteristics of Appendiceal Tumors in Japan: A Multicenter Collaborative Retrospective Clinical Study- A Japanese Nationwide Survey. Dis Colon Rectum.63(10):1403-10. 2020
114. Bando H, Kagawa Y, Kato T, Akagi K, Denda T, Nishina T, Komatsu Y, Oki E, Kudo T, Kumamoto H, Yamanaka T, Yoshino T. A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer (vol 120, pg 982, 2020). British Journal of Cancer.122(8):1271-. 2020
115. Sueda T, Murata K, Takeda T, Kagawa Y, Hasegawa J, Komori T, Noura S, Ikeda K, Tsujie M, Ohue M, Ota H, Ikenaga M, Hata T, Matsuda C, Mizushima T, Yamamoto H, Sekimoto M, Nezu R, Mori M, Doki Y. Survival outcomes of appendiceal mucinous neoplasms by histological type and stage: Analysis of 266 cases in a multicenter collaborative retrospective clinical study. Annals of Gastroenterological Surgery.3(3):291-300. 2019
116. Shitara K, Yamanaka T, Denda T, Tsuji Y, Shinozaki K, Komatsu Y, Kobayashi Y, Furuse J, Okuda H, Asayama M, Akiyoshi K, Kagawa Y, Kato T, Oki E, Ando T, Hagiwara Y, Ohashi Y, Yoshino T. REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients. Annals of Oncology.30(2):259-65. 2019
117. Naito A, Kagawa Y, Kawai K, Takeno A, Takeda Y, Ohtsuka M, Suzuki Y, Imasato M, Fujie Y, Nakaba H, Akamatsu H, Murata K. Surgical Resection of Colorectal Cancer With Distant Metastases to Other than Liver or Lung. In Vivo.33(5):1605-8. 2019
118. Bando H, Kagawa Y, Kato T, Akagi K, Denda T, Nishina T, Komatsu Y, Oki E, Kudo T, Kumamoto H, Yamanaka T, Yoshino T. A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer. British Journal of Cancer.120(10):982-6. 2019
119. Oki E, Kato T, Bando H, Yoshino T, Muro K, Taniguchi H, Kagawa Y, Yamazaki K, Yamaguchi T, Tsuji A, Iwamoto S, Nakayama G, Emi Y, Touyama T, Nakamura M, Kotaka M, Sakisaka H, Yamanaka T, Kanazawa A. A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study. Clinical Colorectal Cancer.17(2):147-55. 2018
120. Nishimura J, Hasegawa J, Kato T, Yoshioka S, Noura S, Kagawa Y, Yasui M, Ikenaga M, Murata K, Hata T, Matsuda C, Mizushima T, Yamamoto H, Doki Y, Mori M. Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer. Cancer Chemotherapy and Pharmacology.82(4):707-16. 2018
121. Iwamoto S, Ooki A, Morita S, Hara H, Tanioka H, Satake H, Kataoka M, Kotaka M, Kagawa Y, Nakamura M, Shingai T, Ishikawa M, Miyake Y, Sudo T, Hashiguchi Y, Yabuno T, Sakamoto J, Tsuji A, Ando M, Yamaguchi K. A prospective Phase II study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK trial. Cancer Medicine.7(9):4217-27. 2018
122. Tamura S, Takeno A, Taniguchi H, Katsura Y, Ohmura Y, Kagawa Y, Sakisaka H, Takeda Y, Kato T. Induction Chemotherapy Using FAP for Patients with Stage II/III Squamous Cell Carcinoma of the Esophagus. Anticancer Research.35(5):2975-82. 2015
123. Takahashi H, Nishimura J, Kagawa Y, Kano Y, Takahashi Y, Wu X, Hiraki M, Hamabe A, Konno M, Haraguchi N, Takemasa I, Mizushima T, Ishii M, Mimori K, Ishii H, Doki Y, Mori M, Yamamoto H. Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer. Molecular Cancer Therapeutics.14(7):1705-16. 2015
124. Nonaka R, Miyake Y, Hata T, Kagawa Y, Kato T, Osawa H, Nishimura J, Ikenaga M, Murata K, Uemura M, Okuzaki D, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M. Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer. International Journal of Oncology.47(3):1097-102. 2015
125. Naito A, Yamamoto H, Kagawa Y, Naito Y, Okuzaki D, Otani K, Iwamoto Y, Maeda S, Kikuta J, Nishikawa K, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Ishii H, Doki Y, Mori M, Ishii M. RFPL4A Increases the G1 Population and Decreases Sensitivity to Chemotherapy in Human Colorectal Cancer Cells. Journal of Biological Chemistry.290(10):6326-37. 2015
126. Nonaka R, Nishimura J, Kagawa Y, Osawa H, Hasegawa J, Murata K, Okamura S, Ota H, Uemura M, Hata T, Takemasa I, Mizushima T, Okuzaki D, Yamamoto H, Doki Y, Mori M. Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer. Oncology Reports.32(6):2354-8. 2014
127. Matsumoto S, Fujii S, Sato A, Ibuka S, Kagawa Y, Ishii M, Kikuchi A. A combination of Wnt and growth factor signaling induces Arl4c expression to form epithelial tubular structures. Embo Journal.33(7):702-18. 2014
128. Maeda S, Wada H, Naito Y, Nagano H, Simmons S, Kagawa Y, Naito A, Kikuta J, Ishii T, Tomimaru Y, Hama N, Kawamoto K, Kobayashi S, Eguchi H, Umeshita K, Ishii H, Doki Y, Mori M, Ishii M. Interferon-α Acts on the S/G2/M Phases to Induce Apoptosis in the G1 Phase of an IFNAR2-expressing Hepatocellular Carcinoma Cell Line. Journal of Biological Chemistry.289(34):23786-95. 2014
129. Ohta K, Haraguchi N, Kano Y, Kagawa Y, Konno M, Nishikawa S, Hamabe A, Hasegawa S, Ogawa H, Fukusumi T, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Noguchi Y, Ozaki M, Kudo T, Sakai D, Satoh T, Fukami M, Ishii M, Yamamoto H, Doki Y, Mori M, Ishii H. Depletion of JARID1B induces cellular senescence in human colorectal cancer. International Journal of Oncology.42(4):1212-8. 2013
